A detailed history of Louisbourg Investments Inc. transactions in Amgen Inc stock. As of the latest transaction made, Louisbourg Investments Inc. holds 1,700 shares of AMGN stock, worth $482,833. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,700
Previous 1,700 -0.0%
Holding current value
$482,833
Previous $548 Million 19.11%
% of portfolio
0.12%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jan 29, 2025

SELL
$262.75 - $319.31 $210,200 - $255,448
-800 Reduced 32.0%
1,700 $531 Million
Q4 2023

Jan 29, 2025

BUY
$255.7 - $288.46 $639,250 - $721,150
2,500 New
2,500 $720 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Louisbourg Investments Inc. Portfolio

Follow Louisbourg Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisbourg Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Louisbourg Investments Inc. with notifications on news.